FDA Commissioner Hahn’s Priorities Include Workplace Development Issues, Data Collection

Among Stephen Hahn’s priorities and long-term ambitions for his time at the US agency are retaining and recruiting the best possible professional staff, and collection and use of data, regulatory consultants and attorneys say.

Stephen Hahn of MD Anderson Cancer Center is expected to be nominated for FDA commissioner

More from Regulation

More from Policy & Regulation